Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinfeng Qiu

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of Nanomedicine|November 11, 2011
Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34ALing Zhang, Xiang Gao, Ke Men, et al.
International Journal of Nanomedicine|June 5, 2012
Treating acute cystitis with biodegradable micelle-encapsulated quercetinBi Lan Wang, Xiang Gao, Ke Men, et al.
Frontiers in Immunology|November 26, 2025
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trialNing Mo, Kai Hu, Zhiming Zeng, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of Nanomedicine|November 11, 2011
Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34ALing Zhang, Xiang Gao, Ke Men, et al.
International Journal of Nanomedicine|June 5, 2012
Treating acute cystitis with biodegradable micelle-encapsulated quercetinBi Lan Wang, Xiang Gao, Ke Men, et al.
Frontiers in Immunology|November 26, 2025
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trialNing Mo, Kai Hu, Zhiming Zeng, et al.
Pageof 3